Segui
Cristina Mussini
Cristina Mussini
Professor of Infectious Diseases, Univ. of Modena and Reggio Emilia
Email verificata su unimore.it
Titolo
Citata da
Citata da
Anno
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
21002003
Monkeypox virus infection in humans across 16 countries—April–June 2022
JP Thornhill, S Barkati, S Walmsley, J Rockstroh, A Antinori, LB Harrison, ...
New England Journal of Medicine 387 (8), 679-691, 2022
15562022
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
14812006
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
11532008
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
G Guaraldi, M Meschiari, A Cozzi-Lepri, J Milic, R Tonelli, M Menozzi, ...
The Lancet Rheumatology 2 (8), e474-e484, 2020
10282020
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of …
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...
The Lancet 393 (10189), 2428-2438, 2019
10042019
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
S De Biasi, M Meschiari, L Gibellini, C Bellinazzi, R Borella, L Fidanza, ...
Nature communications 11 (1), 3434, 2020
7382020
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study
G Ferrara, M Losi, R D'Amico, P Roversi, R Piro, M Meacci, B Meccugni, ...
The Lancet 367 (9519), 1328-1334, 2006
7192006
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
6972021
Common genetic variation and the control of HIV-1 in humans
J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ...
PLoS genetics 5 (12), e1000791, 2009
4682009
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
4352010
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
B Ledergerber
The Lancet 364 (9428), 51-62, 2004
3912004
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 …
P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ...
The Lancet 393 (10167), 143-155, 2019
3892019
Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease
G Monti, M Galli, F Invernizzi, P Pioltelli, F Saccardo, A Monteverde, ...
QJM: An International Journal of Medicine 88 (2), 115-126, 1995
3711995
Long-term consequences of COVID-19: research needs
D Yelin, E Wirtheim, P Vetter, AC Kalil, J Bruchfeld, M Runold, G Guaraldi, ...
The Lancet Infectious Diseases 20 (10), 1115-1117, 2020
3662020
Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial
D Yahav, E Franceschini, F Koppel, A Turjeman, T Babich, R Bitterman, ...
Clinical Infectious Diseases 69 (7), 1091-1098, 2019
3442019
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase–producing K. pneumoniae
M Tumbarello, EM Trecarichi, A Corona, FG De Rosa, M Bassetti, ...
Clinical Infectious Diseases 68 (3), 355-364, 2019
3362019
Cancer immunotherapy with anti-CTLA-4 monoclonal antibodies induces an inflammatory bowel disease
L Marthey, C Mateus, C Mussini, M Nachury, S Nancey, F Grange, ...
Journal of Crohn's and Colitis 10 (4), 395-401, 2016
3212016
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study
C Mussini, P Lorenzini, A Cozzi-Lepri, G Lapadula, G Marchetti, E Nicastri, ...
The lancet HIV 2 (3), e98-e106, 2015
3122015
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort …
Collaboration of Observational HIV Epidemiological Research Europe (COHERE ...
International journal of epidemiology 41 (2), 433-445, 2012
3092012
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20